NCT00267917View on ClinicalTrials.gov

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 17, 2006

Primary Completion Date

February 27, 2006

Study Completion Date

February 27, 2006

Conditions
Pulmonary Disease, Chronic ObstructiveAsthma
Interventions
DEVICE

Berodual Respimat

DEVICE

Berodual HFA-MDI

Trial Locations (1)

82131

Inamed Research GmbH & Co. KG, Gauting

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00267917 - Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. | Biotech Hunter | Biotech Hunter